Φορτώνει......

Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients

Most patient with acute myeloid leukemia (AML) age ≥ 60 are not offered intensive induction because of high mortality. Phase 2 studies of clofarabine plus low-dose cytarabine (CLDA) as frontline therapy for elderly AML patients demonstrated high response and acceptable toxicity. We hypothesized that...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:	Clin Lymphoma Myeloma Leuk
Κύριοι συγγραφείς:	Takahashi, Koichi, Kantarjian, Hagop, Garcia-Manero, Guillermo, Borthakur, Gautam, Kadia, Tapan, DiNardo, Courtney, Jabbour, Elias, Pierce, Sherry, Estrov, Zeev, Konopleva, Marina, Andreeff, Michael, Ravandi, Farhad, Cortes, Jorge
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	2015
Θέματα:	Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4804759/ https://ncbi.nlm.nih.gov/pubmed/26752456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2015.11.016
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients

Παρόμοια τεκμήρια